Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The intrathecal analgesy emerges as a therapeutical option to relieve the untreated pain when other treatments have failed, and
in cases with high opium doses presenting unacceptable secondary effects
OBJECTIVES: To analyze the viability of the home handling of patients with intratecales pumps by a team of palliative cares
supported at home
MATERIAL AND METHODOLOGY: Retrospective descriptive analysis of terminal patients with intratecales pumps
implanted to control the pain.
Variables analyzed: age, sex, pathology type, functional capacity, survival from the pump implantation, average stay, medication
received, recharged number, secondary effects, necessary doses, adjuvant treatment, hospital transfers avoided and place of
death.
RESULTS: 15 patients with advanced oncology illness is analyzed. Average age 60 (40-75). Males- 60 %. Colon neoplasia:
40 %, Lumb: 26.6 %. Others: 33.4 %. Average Barthel index 38 (10-65). Medium survival since the pump implantation to
the death.137,46 days (10-425). Medium home recharged 3,2 (1-14). No secondary effects were found. Medication used:
Morphine- mÃ?Ânimum dose 3,5 mg / 24 hours- 6,5 mcg / 24 h). Clonidina 0,4 % ( 75 mcg/24 h). Secondary effects: 80%
presented constipation but non of them was hospitalized by intestinal obstruction, 13,3 % showed high blood pressure, a 20
% used Ziconotide, and all of them showed symtoms of alteration on the behavior and alusinations. 60 % presented nausea
and one patient was hospitalized due to emesis. A 100 % needed a rescued treatment and the 93 % adyuvante medication for
its control (pregabalina, dexametasona, AINE, anxiolytic and antidepressant). A 53 % kept a treatment with opioides with
retarded liberation.
7 patients required hospitalization due to emetic syndrome, urinary sepsis, dyspnea, pain, catheter infection, badly function
of the pump and replacement. Death place, hospital 60 %, home 40 %. The 100 % required a progressive increase of opioids as
the illness progressed.
CONCLUSIONS: The intrathecal pumps management can be performed at home safely by advanced Palliative Cares Units
avoiding transfers to the hospital in 48 occasions to recharge the pumps. No problems were found in the recharges at home.